Literature DB >> 23257532

Sai-rei-to-induced lung injury: a case report and brief review of the literature.

Kosaku Komiya1, Hiroshi Ishii, Minoru Ohama, Masahiro Uchida, Tetsuo Tsubone, Tomohiko Iwashita, Hajime Miyajima, Eiji Okabe, Taisuke Matsumoto, Bunroku Matsumoto, Jun-ichi Kadota.   

Abstract

An 81-year-old man was admitted to our hospital due to persistent fever and dyspnea with pulmonary infiltrates. He was treated successfully by discontinuing his current medications, including Sai-rei-to, and administering glucocorticoids. Drug lymphocyte stimulation tests showed a positive result for Sai-rei-to alone, and the resumption of other regular drugs did not re-induce the lung injury. Therefore, we diagnosed the patient with Sai-rei-to-induced lung injury. Sai-rei-to is a combination drug that consists of Sho-saiko-to and Gorei-san. This paper briefly reviews drug-induced lung injury caused by Sai-rei-to or its components with a case report.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257532     DOI: 10.2169/internalmedicine.51.8705

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database.

Authors:  Kiyoka Matsumoto; Satoshi Nakao; Shiori Hasegawa; Toshinobu Matsui; Kazuyo Shimada; Ririka Mukai; Mizuki Tanaka; Hiroaki Uranishi; Mitsuhiro Nakamura
Journal:  SAGE Open Med       Date:  2020-05-06

2.  Severe acute respiratory failure due to Sai-rei-to-induced lung injury successfully treated by multi-modal therapy including immunosuppressive therapy, plasma exchange, and intravenous immunoglobulin: A case report.

Authors:  Midori Yamada; Kei Nakashima; Hiroyuki Ito; Masahiro Aoshima
Journal:  Respir Med Case Rep       Date:  2019-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.